The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

March 12 (Reuters) - Generic drugmaker Viatris (VTRS.O), opens new tab has settled a lawsuit brought by the family of Henrietta Lacks, a Maryland woman whose tissue samples were used without her ...

Over the last year, Viatris has been busy working to resolve FDA concerns at a critical drug manufacturing plant in India while also taking a hard look at its business with an eye on potential cuts.

This press release includes statements that constitute "forward-looking statements." These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of ...

Viatris Inc. (NASDAQ:VTRS) is one of the best healthcare stocks under $50 to invest in. Viatris Inc. (NASDAQ:VTRS) received a rating update from Piper Sandler on January 28, which adjusted the price ...

The transaction accelerates the expiration of biosimilars non-compete restrictions, the company said. The shares are subject to a six-month lock up period. Transaction value will be subject to related ...

Viatris is letting go of the equity stake it’s held in Biocon’s biosimilar subsidiary Biocon Biologics for $815 million, allowing Biocon to fully integrate its subsidiary. The Viatris stake is one of ...

Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...

(RTTNews) - Viatris Inc. (VTRS) announced that it has entered into definitive agreements with Biocon Limited for the sale of its equity stake in Biocon Biologics Limited. Under the agreements, Biocon ...